Inhibition of the inhaled allergen challenge response by the CRTH2 antagonist OC000459 in patients with asthma Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 Source: Eur Respir J 2013; 41: 46-52 Year: 2013
The effect of a leukotriene antagonist, pranlukast, on allergen-induced airway responses and circulating dendritic cells in subjects with atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 414s Year: 2003
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Chemokine and cytokine production in the airway from atopic asthmatics after segmental allergen challenge Source: Eur Respir J 2003; 22: Suppl. 45, 378s Year: 2003
The inhaled PDE4 inhibitor GSK256066 significantly inhibits airway responses following allergen challenge in asthmatics Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008
Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma Source: Eur Respir J 2003; 21: 1046-1049 Year: 2003
Montelukast as add-on therapy to β-agonists and late airway response Source: Eur Respir J 2007; 30: 56-61 Year: 2007
Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 135s Year: 2005
A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma Source: Annual Congress 2006 - Novel treatments for asthma Year: 2006
Expression of CCR3 in bronchial biopsies after allergen challenge in subjects with atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002
Protective effect of inhaled iloprost on specific bronchial challenge in aspirin-sensitive asthma Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis Source: Annual Congress 2011 - T-cell subsets Year: 2011
The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine Source: Annual Congress 2007 - New drugs for asthma Year: 2007
Relationships of mannitol challenge to methacholine challenge and inflammatory markers in asthmatics receiving inhaled corticosteroids Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Tolerance to the protective effect of salmeterol on allergen challenge in mild untreated asthmatics and in moderate asthmatics on inhaled corticosteroid treatment Source: Eur Respir J 2001; 18: Suppl. 33, 103s Year: 2001
The effect of smoking on the response to nasal antigen challenge in patients with allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 217s Year: 2002
Does sputum eosinophil counts predict the response to inhaled corticosteroids in terms of methacholine bronchial responsiveness in steroid naive asthmatics? Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Anti-IL17 treatment controls airway asthmatic responses exacerbated by LPS Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017